Business Description
Pediatrix Medical Group Inc
NAICS : 621498
SIC : 8093
ISIN : US58502B1061
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.93 | |||||
Debt-to-EBITDA | -3.45 | |||||
Interest Coverage | 4 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.06 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.3 | |||||
3-Year EBITDA Growth Rate | -40.8 | |||||
3-Year EPS without NRI Growth Rate | 9.9 | |||||
3-Year FCF Growth Rate | -15.7 | |||||
3-Year Book Growth Rate | 5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 8.32 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 71.68 | |||||
9-Day RSI | 77.26 | |||||
14-Day RSI | 79.22 | |||||
6-1 Month Momentum % | 35.49 | |||||
12-1 Month Momentum % | 35.49 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.42 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.59 | |||||
Days Sales Outstanding | 50.72 | |||||
Days Payable | 8.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | 2.34 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.28 | |||||
Operating Margin % | 8.2 | |||||
Net Margin % | -12.65 | |||||
FCF Margin % | 6.5 | |||||
ROE % | -30.86 | |||||
ROA % | -11.77 | |||||
ROIC % | 8.73 | |||||
ROC (Joel Greenblatt) % | -151.25 | |||||
ROCE % | -12.75 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 9.65 | |||||
PE Ratio without NRI | 11.35 | |||||
PS Ratio | 0.61 | |||||
PB Ratio | 1.73 | |||||
Price-to-Free-Cash-Flow | 10.74 | |||||
Price-to-Operating-Cash-Flow | 8.65 | |||||
EV-to-EBIT | -7.47 | |||||
EV-to-Forward-EBIT | 8.63 | |||||
EV-to-EBITDA | -8.78 | |||||
EV-to-Forward-EBITDA | 7.62 | |||||
EV-to-Revenue | 0.86 | |||||
EV-to-Forward-Revenue | 0.91 | |||||
EV-to-FCF | 15.02 | |||||
Price-to-Projected-FCF | 0.53 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Earnings Yield (Greenblatt) % | -13.38 | |||||
FCF Yield % | 9.05 | |||||
Forward Rate of Return (Yacktman) % | -7.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pediatrix Medical Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 36,029.963 | ||
EPS (TTM) (MXN) | -53.922 | ||
Beta | -0.71 | ||
Volatility % | 69.73 | ||
14-Day RSI | 79.22 | ||
14-Day ATR (MXN) | 4.265547 | ||
20-Day SMA (MXN) | 278.0225 | ||
12-1 Month Momentum % | 35.49 | ||
52-Week Range (MXN) | 146 - 329.84 | ||
Shares Outstanding (Mil) | 85.88 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pediatrix Medical Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pediatrix Medical Group Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Pediatrix Medical Group Inc Frequently Asked Questions
What is Pediatrix Medical Group Inc(MEX:MD)'s stock price today?
When is next earnings date of Pediatrix Medical Group Inc(MEX:MD)?
Does Pediatrix Medical Group Inc(MEX:MD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |